GI & Endoscopy

Thompson Health Gastroenterology is relocating to a new outpatient clinic May 4, the Daily Messenger reports.

The American Gastroenterological Association released a guideline on the consultative management of COVID-19 patients.

CellMax Life released results from its U.S. study of the FirstSight blood test that revealed the test detected colorectal cancer with 100 percent sensitivity at 90 percent specificity.

Phoenix-based Arizona Digestive Health expects patient volumes in May will be just a fraction of what they were before the pandemic, gastroenterologist Paul Berggreen, MD, told Medscape Medical News.

RDD Pharma, Innovate Biopharmaceuticals and Naia Rare Diseases merged and formed 9 Meters Biopharma, which will develop treatments for orphan diseases and unmet needs in gastroenterology.

Here are the five most-read Becker's ASC Review articles for gastroenterologists the week of April 27-May 1:

A combination of liquid biopsy screening tests and conventional screening practices could present a more complete oncology picture, according to a study published in Science. 

Here are six updates from gastroenterology companies and practices from the past week:

Gastroenterology-focused group purchasing organization Gastrologix partnered with Clinical Research Strategy Group to facilitate discounted rates to CSRG's clinical trial management platform.

The American Gastroenterological Association partnered with EndoscopyNow to provide AGA members access to a centralized platform with news, clinical data, procedural insights and product information.